Cargando…

5T4 oncofoetal glycoprotein: an old target for a novel prostate cancer immunotherapy

The tumour-associated antigen 5T4 is an attractive target for cancer immunotherapy. However to date, reported 5T4-specific cellular immune responses induced by various immunisation platforms have been largely weak or non-existent. In the present study, we have evaluated a heterologous prime boost re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cappuccini, Federica, Pollock, Emily, Stribbling, Stephen, Hill, Adrian V.S., Redchenko, Irina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564579/ https://www.ncbi.nlm.nih.gov/pubmed/28537896 http://dx.doi.org/10.18632/oncotarget.17666

Ejemplares similares

Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer
por: Cappuccini, Federica, et al.
Publicado: (2016)

Expression of the 5T4 oncofoetal antigen in renal cell carcinoma: a potential target for T-cell-based immunotherapy
por: Griffiths, R W, et al.
Publicado: (2005)

Heterologous prime-boost vaccination targeting MAGE-type antigens promotes tumor T-cell infiltration and improves checkpoint blockade therapy
por: McAuliffe, James, et al.
Publicado: (2021)

Oncofoetal antigens in cancer of the cervix and ovary.
por: Cauchi, M. N., et al.
Publicado: (1981)

Another oncofoetal antigen in colonic carcinoma.
por: Ma, J., et al.
Publicado: (1980)

Oncofoetal antigen I: a target for immune cytolysis of human cancer.
por: Sidell, N., et al.
Publicado: (1979)

Safety and immunogenicity of novel 5T4 viral vectored vaccination regimens in early stage prostate cancer: a phase I clinical trial
por: Cappuccini, Federica, et al.
Publicado: (2020)

Cross-presentation of the oncofoetal tumor antigen 5T4 from irradiated prostate cancer cells - a key role for Hsp70
por: Salimu, Josephine C, et al.
Publicado: (2014)

Expression of oncofoetal pancreatic antigens in hamster adult pancreas during experimental carcinogenesis.
por: Escribano, M. J., et al.
Publicado: (1985)

Identification of a common oncofoetal protein in x-ray and chemically induced rat gastrointestinal tumours.
por: Stevens, R. H., et al.
Publicado: (1981)

A phase II study of a 5T4 oncofoetal antigen tumour-targeted superantigen (ABR-214936) therapy in patients with advanced renal cell carcinoma
por: Shaw, D M, et al.
Publicado: (2007)

Oncofoetal fibronectin – a tumour-specific marker in detecting minimal residual disease in differentiated thyroid carcinoma
por: Hesse, E, et al.
Publicado: (2005)

Oncofoetal insulin receptor isoform A marks the tumour endothelium; an underestimated pathway during tumour angiogenesis and angiostatic treatment
por: Nowak-Sliwinska, Patrycja, et al.
Publicado: (2018)

Targeting Antigen to the Surface of EVs Improves the In Vivo Immunogenicity of Human and Non-human Adenoviral Vaccines in Mice
por: Bliss, Carly M., et al.
Publicado: (2019)

5T4 oncofoetal antigen is expressed in high risk of relapse childhood pre-B acute lymphoblastic leukemia and is associated with a more invasive and chemotactic phenotype
por: Castro, Fernanda V, et al.
Publicado: (2012)

C6: A Monoclonal Antibody Specific for a Fibronectin Epitope Situated at the Interface between the Oncofoetal Extra-Domain B and the Repeat III8
por: Ventura, Elisa, et al.
Publicado: (2016)

Immunotherapy in Prostate Cancer
por: Fay, Emily K., et al.
Publicado: (2020)

Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
por: Ahmed, Ritaparna, et al.
Publicado: (2023)

Characterization of Antigenic MHC-Class-I-Restricted T Cell Epitopes in the Glycoprotein of Ebolavirus
por: Powlson, Jonathan, et al.
Publicado: (2019)

Evaluation of Selected Immunomodulatory Glycoproteins as an Adjunct to Cancer Immunotherapy
por: Sekhon, Bhagwant Kaur, et al.
Publicado: (2016)

Discovery and validation of surface N-glycoproteins in MM cell lines and patient samples uncovers immunotherapy targets
por: Oldham, Robyn A A, et al.
Publicado: (2020)

Urinary glycoproteins associated with aggressive prostate cancer
por: Dong, Mingming, et al.
Publicado: (2020)

Comparing Urinary Glycoproteins among Three Urogenital Cancers and Identifying Prostate Cancer-Specific Glycoproteins
por: Chen, Shao-Yung, et al.
Publicado: (2022)

A novel role for an old target: CD45 for breast cancer immunotherapy
por: Raiter, Annat, et al.
Publicado: (2021)

Treatment of prostate cancer: therapeutic potential of targeted immunotherapy with APC8015
por: Bok, Robert A
Publicado: (2008)

Targeted treatment of metastatic castration-resistant prostate cancer with sipuleucel-T immunotherapy
por: Mulders, Peter F., et al.
Publicado: (2015)

Construction of PANoptosis signature: Novel target discovery for prostate cancer immunotherapy
por: Yi, Xianyanling, et al.
Publicado: (2023)

Distinct urinary glycoprotein signatures in prostate cancer patients
por: Kawahara, Rebeca, et al.
Publicado: (2018)

Use of Glycoproteins—Prostate-Specific Membrane Antigen and Galectin-3 as Primary Tumor Markers and Therapeutic Targets in the Management of Metastatic Prostate Cancer
por: Sharma, Satish, et al.
Publicado: (2022)

Immunotherapy in metastatic prostate cancer
por: Slovin, Susan F.
Publicado: (2016)

Combination Immunotherapy in Prostate Cancer
por: Baxevanis, Constantin N., et al.
Publicado: (2022)

Neuroblastoma Origin and Therapeutic Targets for Immunotherapy
por: Kholodenko, Irina V., et al.
Publicado: (2018)

IL‐1β Is an Androgen‐Responsive Target in Macrophages for Immunotherapy of Prostate Cancer
por: Wang, Deng, et al.
Publicado: (2023)

Immunotherapy and Immunotherapy Combinations in Metastatic Castration-Resistant Prostate Cancer
por: Bansal, Dhruv, et al.
Publicado: (2021)

Guanylate binding protein 5: Impairing virion infectivity by targeting retroviral envelope glycoproteins
por: Hotter, Dominik, et al.
Publicado: (2016)

Targeting of viral glycoproteins to the Golgi complex
por: Hobman, Tom C.
Publicado: (1993)

HNSCC: Tumour Antigens and Their Targeting by Immunotherapy
por: von Witzleben, Adrian, et al.
Publicado: (2020)

Immunotherapy-induced antibodies to endogenous retroviral envelope glycoprotein confer tumor protection in mice
por: Kang, Byong H., et al.
Publicado: (2021)

A Computational Workflow to Predict Biological Target Mutations: The Spike Glycoprotein Case Study
por: Cozzini, Pietro, et al.
Publicado: (2023)

Pyopneumothorax with Stocker type III congenital cystic adenomatoid malformation in a 5-month-old infant
por: Chilkar, Sujeet M, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5sg85mf0kfvsj8k85mudt4415a